商湯(00020.HK)夥沙地SCAI合作 建設人工智能實驗室
商湯(00020.HK)公布,與沙地阿拉伯人工智能公司(SCAI)達成合作協議,SCAI將為商湯與沙地國家主權基金PIF於去年底成立的合資公司SenseTime MEA,投資7.76億沙地里亞爾(約14.29億元人民幣),並以此為主體在當地建設高端人工智能實驗室,創造就業機會,強化沙地作為中東區域領先的人工智能技術中心的戰略定位。
據此,雙方將共同開發智慧城市、智慧商業、智慧醫療、教育等領域的人工智能解決方案,並推動商湯尖端計算機視覺和深度學習平台在當地應用,促進沙地本地相關知識及技術的發展。人工智能實驗室將作為專項研究與開發中心,透過商湯在該領域的知識,協助培育當地人才。(ji/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.